Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5183386
Max Phase: Preclinical
Molecular Formula: C24H30N4O4S2
Molecular Weight: 502.66
Associated Items:
ID: ALA5183386
Max Phase: Preclinical
Molecular Formula: C24H30N4O4S2
Molecular Weight: 502.66
Associated Items:
Canonical SMILES: CCCCOC(=O)NS(=O)(=O)c1sc(CCC)nc1-c1ccc(Cn2ccnc2C2CC2)cc1
Standard InChI: InChI=1S/C24H30N4O4S2/c1-3-5-15-32-24(29)27-34(30,31)23-21(26-20(33-23)6-4-2)18-9-7-17(8-10-18)16-28-14-13-25-22(28)19-11-12-19/h7-10,13-14,19H,3-6,11-12,15-16H2,1-2H3,(H,27,29)
Standard InChI Key: XAMPSDSVTSVDNL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 502.66 | Molecular Weight (Monoisotopic): 502.1708 | AlogP: 5.10 | #Rotatable Bonds: 11 |
Polar Surface Area: 103.18 | Molecular Species: ACID | HBA: 8 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.56 | CX Basic pKa: 6.74 | CX LogP: 3.89 | CX LogD: 4.35 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.37 | Np Likeness Score: -1.04 |
1. Gopalan G, Palo-Nieto C, Petersen NN, Hallberg M, Larhed M.. (2022) Angiotensin II AT2 receptor ligands with phenylthiazole scaffolds., 65 [PMID:35550979] [10.1016/j.bmc.2022.116790] |
Source(1):